Motley Fool

3 reasons why Neil Woodford is a successful investor

While Warren Buffett is arguably the most famous investor in the US, in the UK that title probably belongs to Neil Woodford. Both investors have delivered excellent returns over a long period. In Neil Woodford's case, he has focused on high dividend paying stocks in tobacco and healthcare, while also investing for the long term. Here's why that strategy has made him a successful investor.

Should you buy these two FTSE 250 champions?

Investing in high quality mid-cap stocks can be a great way to boost your portfolio returns and the FTSE 250 is home to many fast growing mid-cap-sized companies. Here's a look at two FTSE 250 stocks that have generated excellent returns for shareholders in recent years.

2 perfect FTSE 100 stocks for growth AND income investors!

I've long been ultra-bullish over drugs giant GlaxoSmithKline's (LSE:GSK) future earnings prospects. And a steady stream of testing data suggests that the patient is firmly back in recovery following years of patent expirations smashing the top line.

Just this week the Brentford business presented its Sirukumab treatment for rheumatoid arthritis to EU regulators. And submission in the US is expected in the coming weeks.

Are these 2 healthcare stocks ‘screaming buys’?

Alliance Pharma (LSE:APH) and Advanced Medical Solutions (LSE:AMS) have both released upbeat results today giving us clues as to whether now is the right time to buy them for the long term.

Are these the best dividends money can buy?

If you're looking for dividend yields that are both high and reliable, it's tempting to focus on the FTSE's biggest dividend stocks.

What's unusual about the current market is that the biggest dividend stock of them all -- Royal Dutch Shell (LSE:RDSB) -- is currently offering a dividend yield of 7.4%.

Shell is famous for not having cut its dividend since World War II. Chief executive Ben van Beurden is keen to maintain this record, which attracts a lot of long-term shareholders. But a yield this high is very often a sign of a dividend that's unaffordable.

Can these Q3 crashers go out with a bang?

To say that Aggreko (LSE:AGK) has had a quarter to forget would be something of a huge understatement. The power generator provider has shed 22% of its value since the end of June, putting paid to its heady ascent enjoyed since the spring.

Share prices took a dive in August after Aggreko produced a worrisome trading update. The business advised that revenues slumped 12% during January-June, to £685m, a result that drove profit before tax 31% lower to £61m.

Are these two companies the hottest oil stocks around?

This year has been remarkable for both Hurricane Energy  (LSE:HUR) and Sound Energy  (LSE:SOU). Positive well results and strong buying of stock have sent the shares up 250% and 445% respectively since January. 

Will this resources stock soar by 20%+ after today’s results?

Rockhopper Exploration (LSE:RKH) has released an upbeat set of half-year results today. They provide guidance as to whether its shares have 20%-plus upside and if it's a better buy than a more established resources peer such as Glencore (LSE:GLEN).

Should you buy these Brexit bouncers after today’s results?

The shares of many UK-focused companies were hit hard in the aftermath of the EU referendum. Some continue to languish at depressed levels, but some have recovered pretty strongly.

Two of the latter have released results this morning, and I reckon these Brexit bouncers continue to offer great value for investors today.

Five rules to help you become an ISA millionaire

Most investors dream of one day becoming a millionaire. Becoming an ISA millionaire is an even more attractive goal due to the tax-free nature of the ISA wrapper.

In fact, the tax treatment of investments held within an ISA makes it easier to reach millionaire status as there's no need to pay tax on capital gains and income, taxes which can be incredibly destructive to wealth creation in the long-term.

Syndicate content